nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Capecitabine Treatment: A Safe and Effective Therapy in the Field of Oncology
|
Beenet, Linda |
|
|
20 |
3 |
p. e194 |
artikel |
2 |
Early Onset Colorectal Adenocarcinoma in a 15-Year-Old with Pathogenic Germline Mutations in APC and MLH1: A Case Report
|
Buendia, Matthew A. |
|
|
20 |
3 |
p. 197-200 |
artikel |
3 |
Editorial Board
|
|
|
|
20 |
3 |
p. A1 |
artikel |
4 |
Effect of Adding Bevacizumab to Chemotherapy on Pathologic Response to Preoperative Systemic Therapy for Resectable Colorectal Liver Metastases: A Systematic Review and Meta-analysis
|
Jácome, Alexandre A. |
|
|
20 |
3 |
p. 265-272 |
artikel |
5 |
Epidemiology and Outcomes of Patients With Brain Metastases From Colorectal Cancer—Who Are These Patients?
|
Bonadio, Renata Colombo |
|
|
20 |
3 |
p. e195-e200 |
artikel |
6 |
Feasibility, Safety, and Preliminary Efficacy of Exercise During and After Neoadjuvant Rectal Cancer Treatment: A Phase II Randomized Controlled Trial
|
Morielli, Andria R. |
|
|
20 |
3 |
p. 216-226 |
artikel |
7 |
Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study
|
Eisele, Yannick |
|
|
20 |
3 |
p. e165-e172 |
artikel |
8 |
Impact of Treatment Coordination on Overall Survival in Rectal Cancer
|
Biju, Kevin |
|
|
20 |
3 |
p. 187-196 |
artikel |
9 |
Nonoperative Rectal Cancer Management With Short-Course Radiation Followed by Chemotherapy: A Nonrandomized Control Trial
|
Kim, Hyun |
|
|
20 |
3 |
p. e185-e193 |
artikel |
10 |
Patient Risk Subgroups Predict Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer Patients Following Neoadjuvant Chemoradiation and Total Mesorectal Excision
|
Naffouje, Samer |
|
|
20 |
3 |
p. e155-e164 |
artikel |
11 |
Personalizing First-Line Systemic Therapy in Metastatic Colorectal Cancer: Is There a Role for Initial Low-Intensity Therapy in 2021 and Beyond? A Perspective From Members of the Australasian Gastrointestinal Trials Group
|
Dunn, Catherine |
|
|
20 |
3 |
p. 245-255 |
artikel |
12 |
Prognostic and Predictive Value of Tumor Budding in Colorectal Cancer
|
Mitrovic, Bojana |
|
|
20 |
3 |
p. 256-264 |
artikel |
13 |
Real-World Evidence on Second-Line Treatment of Metastatic Colorectal Cancer Using Fluoropyrimidine, Irinotecan, and Angiogenesis Inhibitor
|
Yamazaki, Kentaro |
|
|
20 |
3 |
p. e173-e184 |
artikel |
14 |
Real-World Outcomes of Oxaliplatin-Based Chemotherapy on R0 Resected Colonic Liver Metastasis
|
Bosma, Nicholas A. |
|
|
20 |
3 |
p. e201-e209 |
artikel |
15 |
Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients: A Multi-institution Real Life Clinical Data
|
Vitale, Pasquale |
|
|
20 |
3 |
p. 227-235 |
artikel |
16 |
Squamous Cell Carcinoma of the Anal Verge with Sigmoid Colon Metastasis
|
Livingston, Austin J. |
|
|
20 |
3 |
p. e210-e213 |
artikel |
17 |
Table of contents
|
|
|
|
20 |
3 |
p. A2-A4 |
artikel |
18 |
The Landscape of PIK3CA Mutations in Colorectal Cancer
|
Voutsadakis, Ioannis A. |
|
|
20 |
3 |
p. 201-215 |
artikel |
19 |
Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact Analysis
|
Hanna, Catherine R. |
|
|
20 |
3 |
p. 236-244 |
artikel |
20 |
Use of Uridine Triacetate to Reverse Severe Persistent Myelosuppression Following 5-fluorouracil Exposure in a Patient With a c.557A>G Heterozygous DPYD Variant
|
Leung, Michael |
|
|
20 |
3 |
p. 273-278 |
artikel |